31 KongF.WuT.DaiJ.ZhaiZ.CaiJ.ZhuZ.et al (2023)
Coviello says that when people begin taking semaglutide, they report less hunger and decreases in cravings for fatty foods and sweets, indicating that the drugs affect appetite pathways in the brain
What Is the Maintenance Dose for Tirzepatide
Read more: Are you at a higher risk for breast cancer
Zepbound Switching: How to Transition From or To Other GLP-1/GIP Drugs Safely Zepbound Switching: How to Transition From or To Other Drugs in Class At a glance Drug / Zepbound (tirzepatide), Eli Lilly Drug class / Dual GIP and GLP-1 receptor agonist Approved indication / Chronic weight management in adults with BMI 30, or 27 with one weight-related comorbidity Dosing frequency / Once weekly subcutaneous injection Starting dose / 2.5 mg weekly, escalated every 4 weeks Maximum dose / 15 mg weekly Key trial / SURMOUNT-1 (N=2,539): 20.9% mean body-weight loss at 72 weeks on 15 mg Half-life / Approximately 5 days (supports once-weekly dosing) Common switch scenarios / Semaglutide to tirzepatide, liraglutide to tirzepatide, tirzepatide to oral semaglutide FDA approval date / November 8, 2023 (weight management indication) How Zepbound Works: Mechanism at the Receptor Level Zepbound binds both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor
When considering various injectable weight loss support options, you can expect differences in: Administration frequency : Most require once-weekly injections under the skin
